Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Presenting with at least two comparable, discrete, and separate partial thickness thermal burns, as determined by the Investigator, measuring 50 - 1,000 cm2 each~* Study wounds identified are partial thickness depth~* KeraStat Gel and SSD can be applied to randomized study burn wounds as definitive care treatment within 24 hours from time of injury\]~* Overall total body surface area burned \< 20%~Exclusion Criteria:~* Pregnant or nursing~* Prisoner~* Presence of inhalation injury, as determined by the Investigator~* Injury requiring formal intravenous fluid resuscitation~* Concomitant non-thermal traumatic injuries~* Chronic medical conditions including, but not limited to, documented renal impairment (Cr \> 2.5 mg/dL), hepatic impairment (Total bilirubin \> 2.5 mg/dL), thromboembolic disorders, active infection in study wound areas, uncontrolled diabetes (HbA1C \> 7%), HIV infection, history of melanoma or systemic malignancy within the last 10 years~* Receiving corticosteroids, immunosuppressive agents, radiation or chemotherapy, topical growth factors, or any other medication the Investigator feels will affect wound healing~* Not expected to live at least 13 months post-burn~* Received an investigational drug or biologic within 3 months prior to injury~* Previously treated with a skin graft at either of the treatment sites~* Chemical or electrical burn~* Known or documented allergy to sulfonamides~* Proposed study wounds are full thickness~* Any condition the Investigator determines will compromise subject safety or prevent the subject from completing the study

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- KeraStat Gel (Type: EXPERIMENTAL): Each enrolled subject will have at least one eligible burn randomized to the KeraStat Gel arm. This burn will be dressed with KeraStat Gel and covered by a secondary dressing. Subjects will be instructed to change the dressing and re-apply the KeraStat Gel per the instructions for use (at least every 3 days).
- Silver Sulfadiazine (Type: ACTIVE_COMPARATOR): Each enrolled subject will have at least one eligible burn randomized to the Silver Sulfadiazine arm. This burn will be dressed with the Silver Sulfadiazine and covered by a secondary dressing. Subjects will be instructed to change the dressing and re-apply the Silver Sulfadiazine per the institution's Standard of Care instructions.

Based on this trial design, predict the completion outcome and termination type (if applicable).